Status:

UNKNOWN

Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis

Lead Sponsor:

University of Naples

Conditions:

Peripheral Vascular Diseases

Eligibility:

All Genders

45-90 years

Phase:

PHASE1

Brief Summary

Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic limbs has been shown to improve collateral vessel formation. In the present study the safety and feasibility of...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of third or fourth class of peripheral atherosclerosis

Exclusion

  • Insuline dependent diabetes
  • Cancer

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

End Date :

April 1 2006

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00306085

Start Date

April 1 2005

End Date

April 1 2006

Last Update

March 22 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Naples

Naples, Italy, 80134

Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis | DecenTrialz